Page last updated: 2024-10-30

memantine and Movement Disorders

memantine has been researched along with Movement Disorders in 2 studies

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneider, E1
Fischer, PA1
Clemens, R1
Balzereit, F1
Fünfgeld, EW1
Haase, HJ1
Andreassen, OA1
Aamo, TO1
Jøorgensen, HA1

Trials

1 trial available for memantine and Movement Disorders

ArticleYear
[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study].
    Deutsche medizinische Wochenschrift (1946), 1984, Jun-22, Volume: 109, Issue:25

    Topics: Administration, Oral; Aged; Amantadine; Clinical Trials as Topic; Female; Humans; Male; Memantine; M

1984

Other Studies

1 other study available for memantine and Movement Disorders

ArticleYear
Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats.
    British journal of pharmacology, 1996, Volume: 119, Issue:4

    Topics: Animals; Female; Haloperidol; Memantine; Movement Disorders; Rats; Rats, Sprague-Dawley

1996